drugset / Trial / NCT01753336

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

NCT01753336 ↗

Phase 3 Completed 112 enrolled Ipsen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the protocol is to assess the long term safety of repeat treatment cycles of Dysport® 500 U using 2 mL dilution scheme for the treatment of Cervical Dystonia. This is an extension study to study A-TL-52120-169 (hereafter referred to as Study 169).

Timeline

Start
2013-03
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 500 iu Intramuscular

Indications